A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Thursday, February 9 | 12-2 pm ET | Virtual In this mini symposium, the CDC Office of Genomics and Precision Public Health will reflect on 25 years of progress in public health genomics around the world, review past and current achievements in the field, discuss the role of public health programs in translating advances in […]
Thursday, October 26 | 11 a.m. - 12 p.m. ET | Online CDC Webinar - Cost-Effectiveness Analysis in Public Health Genomics and Precision Health: Recent Findings, Methodologic Issues, and the Path Forward Speaker: David Veenstra, PhD Professor in the Department of Pharmacy and the Comparative Health Outcomes, Policy & Economics (CHOICE) Institute University of Washington […]
GMKB